CA Patent

CA3080702C — Alcohol-resistant oral pharmaceutical compositions of lorazepam

Assigned to Edgemont Pharmaceuticals Trust LLC · Expires 2022-10-18 · 4y expired

What this patent protects

Described herein are alcohol-resistant oral pharmaceutical compositions and dosage forms that exhibit reduced drug release in the presence of alcohol. The compositions comprise a substrate comprising a controlled release formulation of lorazepam and an alcohol-resistant coating s…

USPTO Abstract

Described herein are alcohol-resistant oral pharmaceutical compositions and dosage forms that exhibit reduced drug release in the presence of alcohol. The compositions comprise a substrate comprising a controlled release formulation of lorazepam and an alcohol-resistant coating surrounding the substrate.

Drugs covered by this patent

Patent Metadata

Patent number
CA3080702C
Jurisdiction
CA
Classification
—
Expires
2022-10-18
Drug substance claim
No
Drug product claim
No
Assignee
Edgemont Pharmaceuticals Trust LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.